The present invention is directed to anhydrous and solvated, crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide, pharmaceutical compositions containing said crystalline forms and their use in the treatment epilepsy and related disorders.
本发明涉及N-(苯并[b]
噻吩-3-基甲基)-磺酰胺的无
水和溶剂化结晶形式,含有该晶体形式的制药组合物及其在治疗癫痫和相关疾病中的应用。